Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Erin L McDearmon-Blondell"'
Autor:
Laura C Coates, William Tillett, Maria-Antonietta D'Agostino, Proton Rahman, Frank Behrens, Erin L McDearmon-Blondell, Xianwei Bu, Liang Chen, Mudra Kapoor, Philip G Conaghan, Philip Mease
Background Many patients with psoriatic arthritis do not reach minimal disease activity (MDA) on methotrexate alone. This phase 4 open-label study aimed to compare attainment of MDA following introduction of adalimumab with methotrexate escalation in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4ada55eec13d6e512d0cfd9dd060926
https://eprints.whiterose.ac.uk/186606/1/PIIS266599132200008X.pdf
https://eprints.whiterose.ac.uk/186606/1/PIIS266599132200008X.pdf
Autor:
Peter Nash, Pascal Richette, Laure Gossec, Antonio Marchesoni, Christopher Ritchlin, Koji Kato, Erin L McDearmon-Blondell, Elizabeth Lesser, Reva McCaskill, Dai Feng, Jaclyn K Anderson, Eric M Ruderman
Publikováno v:
Rheumatology
Rheumatology, Oxford University Press (OUP), In press, ⟨10.1093/rheumatology/keab905⟩
Rheumatology, Oxford University Press (OUP), In press, ⟨10.1093/rheumatology/keab905⟩
Objective To assess the efficacy and safety of upadacitinib (UPA), an oral Janus kinase inhibitor, as monotherapy or in combination with non-biologic DMARDs (nbDMARDs) in patients with PsA. Methods Pooled data were analysed from patients with prior i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::329575077d075063cfd778fab768d865
https://pubmed.ncbi.nlm.nih.gov/34864911
https://pubmed.ncbi.nlm.nih.gov/34864911
